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Comparative genomic hybridizationHypersensitivity to radiation exposure is a major challenge to radiotherapy in the treatment of cancer
patients. Copy number variations (CNVs) are believed to identify genomic regions of functional signiﬁcance for
radiosensitivity (RS) but have yet to be systematically investigated. We used Affymetrix 6.0 SNP arrays to survey
common CNVs in a cohort of 50 radiosensitive lymphoblastoid cell lines (RS-LCLs) derived from patients with
undiagnosed diseases. A total of 317 CNVs that were present in at least 10% of the studied cell lines were identi-
ﬁed. Three hundred and eight CNVs overlappedwith polymorphic CNVs, 13 ofwhichwere signiﬁcantly enriched
in the RS-LCLs compared to the reference. The remaining 9 CNVs were novel. Themajority of these enriched and
novel CNVs were chromosomal gains. The dominance of the chromosomal gains over losses is inconsistent with
the traditional concept of molecular basis of RS and suggests more complex genetic mechanisms for RS.
© 2011 Elsevier Inc. All rights reserved.1. Introduction
Exposure of cells to ionizing radiation causes DNAdamage including
single-strand breaks, base damage, double-strand breaks and DNA-
protein cross-links [1–2]. The majority of DNA damage can be repaired
rapidly and efﬁciently by endogenous repairing systems. However,
some individuals have compromised repairing system, and are not
able to detect and/or repair DNA damage efﬁciently, resulting in high
sensitivity to radiation-induced toxicity. A successful radiotherapy
requires maximizing radiation doses to cancer cells while minimizing
damage to surrounding healthy tissue [3]. The severe toxicity in radio-
sensitive (RS) patients limits the effective doses that can be safely
given to the majority, and has become a major challenge in the treat-
ment of cancer patients by radiotherapy.
The genetic basis of RS has been a subject of intensive studies in
the past several decades. The molecular picture of RS is emerging
[4–5] but remains elusive. Researchers have recognized that a large
number of genes are involved in DNA repair. Those genes work in a
coordinated fashion to form repair pathways that are further coordi-
nated with other metabolic processes, such as cell cycle control, to
optimize the prospects of DNA repair [6]. It has been fully appreciated
that the mutations of those genes in the repair pathways are largely
responsible for RS [7]. Many of those genes have been identiﬁed, in-
cluding ATR gene involved in the DNA damage response [8], RAD51
gene vital for repair by homologous recombination and BLM geneLaboratoryMedicine, University
geles, CA 90095, USA. Fax: +1
rights reserved.opening up the DNA helix for repair. Some of those genes were iden-
tiﬁed in RS individuals with established disorders, such as ATM genes
in the ataxia telangiectasia, NBN gene in the Nijmegen breakage syn-
drome and BLM gene in the Bloom's syndrome patients [7,9–10]. How-
ever, some apparent normal persons have also been found to be highly
RS, suggesting that molecular mechanisms underlying the RS are com-
plex and beyond simple gene mutation (loss of function).
One of the plausible alternative mechanisms regulating RS is copy-
number variations (CNVs). These CNVs can range in size from kilo-
bases (kb) to megabases (Mb) that are not identiﬁable by conventional
chromosomal banding [11]. These CNVs may convey an RS phenotype
through gene dosage-mediated change of gene expression. When a
CNV (deleted or duplicated region) harbors a DNA repair pathway-
related gene, the CNV can affect a RS phenotype. A number of studies
using genetic approaches have shown that modulating the expression
levels of DNA repair genes affects the level of radiation sensitivity.
Rad51, a critical component of the DNA DSB repair pathway, represents
such an example. Vispe et al. demonstrated that the plasmid-mediated
overexpression of Rad51 in Chinese hamster ovary decreased the
radiosensitivity by increasing the homologous recombination proﬁ-
ciency [12]. In contrast, reduction of Rad51 expression using antisense
oligonucleotides increased the radiation sensitivity of glioma cells [13].
The application of array comparative genomic hybridization (aCGH)
technique has led to the discovery of a large number of pathogenic
CNVs [14–16]. These disease associated CNVs have been cataloged in
DECIPHER (Database of Chromosomal Imbalance and Phenotype in
Humans using Ensembl Resources, https://decipher.sanger.ac.uk) and
ECARUCA (European Cytogeneticists Association Register of Unbal-
anced Chromosome Aberrations, http://agserver01). However, this
powerful technology has not been widely used in the ﬁeld of RS. Al-
though Tomoyuki Koshikawa et al. [17] have reported a focused CNV
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SR-1 cells, a comprehensive survey of radiosensitive CNVs is still lacking.
This is largely due to the lack of high-throughput and cost-effective
methods for detecting genome-level CNVs in a large radiosensitive
population.
The present study surveyed common CNVs in 50 well-characterized
human RS-LCLs [18] using the Affymetrix SNP 6.0 array. We identiﬁed a
number of RS-associated CNVs that are either novel or signiﬁcantly
enriched compared to genetic variant database.2. Results
2.1. Initial assessment of overall chromosomal stability
Five out of 50 RS-LCLs had major chromosomal abnormalities
(>6 Mb deletion or duplication) that involved chr1, chr6, chr11,
chr12, chr13, chr15 and chr16 (Table 1). The sizes of abnormalities
varied from missing or gaining a >6 Mb segment to an entire p/q
arm or a single chromosome. The remaining 45 lines had no major
abnormalities. Compared to advanced cancer cell lines, these RS-
LCLs were genetically relatively stable.2.2. Copy number variations were dominated by genomic gains
Based on our assumption that the RS-associated CNVs are most
likely present in multiple cell lines, we identiﬁed a total of 317
CNVs that were present in at least 10% of the cell lines (2996 gains
and 512 losses across the 50 cell lines). Three hundred and eight of
those CNVs (97%) overlapped with polymorphic CNVs documented
in the database of genomic variants (Supplemental Table 1). Because
some of the pathogenic CNVs are frequently localized within the
polymorphic CNV regions, we ﬁrst identiﬁed CNVs that overlapped,
but signiﬁcantly enriched polymorphic CNVs, and then focused on
the novel CNVs, assuming that they might contain RS-associated
genes.
Of the 308 overlapping CNVs, 13 CNVs were signiﬁcantly enriched
in the 50 RS-LCLs as compared to the polymorphic CNVs in the geno-
mic variant database using Affymetrix GTC 4.0 software (Table 2).
These CNVs were present in at least 10 of the 50 cell lines, and varied
in size from 52 kb to 150 kb. Of the 13 enriched CNVs, 135 were gains
and 34 were losses. Many RefSeq genes are localized within these
CNVs, including LGALS9C, ZNF717 and KCNC4 (see Table 2 for full
list).
Nine novel CNVs were identiﬁed, ranging from 52 kb to 163 kb
(Table 3). Once again, these novel CNVs were dominated by chromo-
somal gains (49 gains and 2 losses) and contained 14 RefSeq genes
and one miRNA. Fig. 2 is a representation of the 81 kb gain across 9Table 1
Major abnormalities detected in the 50 radiosensitive cell lines (>6 Mb deletion or
duplication).
Cell line
name
Copy number
state
Loss/gain Chr Cytoband Size (kb)
RS23 1 Loss 1 Entire p arm
1 Loss 6 Entire chromosome
1 Loss 16 Entire q arm
3 Gain 13 q22.3–q34 36,992
RS42 3 Gain 1 q23.3–q44 85,735
RS54 1 Loss 1 q43–q44 6786
1 Loss 11 q22.1–q23.3 13,075
3 Gain 12 q13.11–q24.33 85,119
RS56 4 Gain 15 Entire chromosome
RS82 1 Loss x p21.1–p22.33 34,830RS cell lines on 12q13.3. miR1228, NDUFA4L2, NXPH4, SHMT2,
STAC3, and LRP1 are localized in this region.
2.3. Validation of CNVs by expression analysis
Taking advantage of our available miRNA proﬁling data from some
of those RS-LCLs, we examined the expression level of miR1228 in 3
of 9 available RS-LCLs cell lines that had a chromosomal gain involved
in miR1228. The results showed that the mean expression level of
miR1228 in 3 RS cell lines was twice as that of 3 normal controls
(Fig. 3, pb0.01). The data indirectly conﬁrmed the 81 kb gain on
12q13.3 as shown in Fig. 2.
3. Discussion
This is the ﬁrst study describing the use of Affymetrix SNP6.0
arrays for detection of RS associated CNVs in a large RS population.
Results showed that these RS cell lines with unknown etiology
were relatively stable with only a few major chromosomal abnor-
malities among the studied cell lines. Thirteen out of 317 identiﬁed
CNVs were signiﬁcantly enriched in the RS-LCLs compared to the
naturally occurring CNVs. We also identiﬁed 9 CNVs that were pre-
sent in >=10% of the 50 RS-LCLs and have not been reported in the
genomic variant database, thus representing novel CNVs. Multiple
RefSeq genes including retinoic acid receptor alpha within those
CNV regions warrant further investigation.
The RS-associated CNVs were dominated by chromosomal gains,
accounting for 80% of the enriched CNVs, and 96% of the novel CNVs.
Our data suggested a possible mechanism that the genes localized at
these duplicated regions negatively regulate those involved in detecting
and/or repairing DNA damage. One such example is miR1228, which is
localized within the 81 kb duplicated region on 12q13.3, and targets
two critical DNA repair genes, TP53 and UBE2B. We are investigating
if the increased expression of miR1228, as conﬁrmed by miRNA array
data, can negatively regulate the expression of those target genes,
which then lead to compromised DNA repair and increased sensitivity
to ionizing radiation.
The chromosomal gains can also affect the function of the DNA re-
pair genes through other mechanisms. We detected a 52 kb ampliﬁ-
cation on 17q21.2, which includes the retinoic acid receptor alpha
(RARA). We speculated that the chromosomal gain will increase the
expression of RARA, and subsequently enhance RARA interactions
with CDK7, PARP1 and TDG. If the above can be conﬁrmed, the “unex-
pected” increase of protein–protein interactions with these potential
DNA repair molecules can disturb the biological balance and act like a
dominant-negative complex to interfere with the normal DNA repair
functions.
A signiﬁcantly enriched 52 kb CNV on 17p11.2 was the only ab-
normality dominated by deletion (31 cell lines with deletion and
only 2 lines with duplication). LGALS9C is localized at this region.
This gene encodes a predicted protein of the same size as and highly
similar sequence to galectin 9. The function of this gene has not yet
been established. Whether this gene has a DNA repair related func-
tion is under investigation.
Many other genes localized within the duplicated regions have ei-
ther unknown function or functions that do not appear to be related
to RS. This study provides a basis for functional evaluation of these
genes in relation to RS. It is also important to remember that some
DNA repair related genes are adjacent to or overlap with polymorphic
CNVs based on the assembly hg18/b36 of the human genome. Given
the inaccurate genomic coordinates of the assembly hg18/b36, the
positions of these genes relative to the CNVs could change based on
the assembly hg19/b37. In fact, the DNA repair gene, POLE, 100%
overlapped with polymorphic CNVs based on hg18/b36, but the
build hg19/b37 gave a new coordinates (133263945–133200347),
which do not overlap with any polymorphic CNV.
Table 2
Signiﬁcantly enriched CNVs detected in the 50 radiosensitive cell lines.
Chrom Start Stop Cytoband Total
Amp
Samples with Amp Total
Del
Samples with Del Length
(bps)
Overlapping
genes
% of
aber
% of
CNV
17 18301042 18352965 17p11.2 2 RS52, 15-RS56 31 RS6, RS61, RS64, RS66, RS14,
RS15, RS17, RS20, A RS-07,
A RS-23, A RS-68, B-28, B-32,
B-36, B-37, B-42, B-60, B-70,
B-72, B-73, B-74, B-81, C RS-02,
C RS-04, C RS-22, C RS-48,
C RS-51, C RS-57, C RS-76,
C RS-77, RS63
51,924 LGALS9C 66% 17%
11 71101690 71155917 11q13.4 18 RS52, A RS-29, A RS-50,
A RS-68, B-32, B-36,
B-37, B-42, B-60, B-72,
B-73, B-74, B-79, B-80,
B-81, B-82, C RS-25,
C RS-51
0 54,228 36% 1%
7 72039040 72096486 7q11.23 13 RS52, RS17, A RS-54, A
RS-68, B-37, B-42, B-70,
B-73, B-74, B-79, B-80,
B-81, B-82
0 57,447 NSUN5P2, TRIM74,
POM121
26% 2%
3 75844047 75984649 3p12.3 13 RS17, RS20, A RS-68,
B-32, B-37, B-42, B-60,
B-73, B-74, B-79, B-81,
B-82, C RS-25
0 140,603 ZNF717 24% 4%
4 4123182 4186066 4p16.2 11 RS6, RS52, A RS-29, A
RS-54, A RS-68, B-36,
B-37, B-70, B-72,
B-74, B-81
0 62,885 22% 1%
4 1.2E+08 119814322 4q26 11 A RS-07, B-28, B-32, B-37,
B-42, B-60, B-73, B-74,
B-81, B-82, C RS-25
0 10,0701 22% 1%
15 28400182 28486739 15q13.2 9 RS56, RS66, RS20, A RS-68,
B-36, B-81, B-82,
C RS-67, RS63
2 B-28, C RS-76 86,558 CHRFAM7A 22% 4%
1 1.11E+08 110580437 1p13.3 10 RS6, RS31, RS52, RS56,
RS61, RS65, RS14,
RS15, RS17, RS18
0 55,143 KCNC4, SLC6A17 20% 1%
3 13625284 13683037 3p25.1 10 RS6, RS52, RS61, RS65,
RS14, RS17, RS18, RS20,
A RS-68, B-70
0 57,754 20% 1%
5 249197 306552 5p15.33 9 RS52, RS64, RS17, RS18,
A RS-68, B-70, C RS-67,
RS08, RS63
1 57,356 CCDC127, SDHA 20% 1%
5 306552 456560 5p15.33 10 RS52, RS64, RS14, RS17,
RS18, A RS-68, B-70,
C RS-67, RS08, RS63
0 150,009 PDCD6, SDHA,
AHRR
20% 1%
16 508928 582622 16p13.3 10 RS47, RS52, RS14, RS15,
RS17, RS18, A RS-68,
B-70, C RS-25, RS08
0 73,695 LINC00235, C16orf11,
NHLRC4, PIGQ,
SOLH, RAB40C
20% 4%
17 16596541 16681617 17p11.2 10 RS52, RS17, A RS-23, B-32,
B-36, B-37, B-74, C RS-51,
C RS-57, RS63
0 85,077 FAM106CP,
USP32P1,
KRT16P2,
CCDC144A
20% 2%
Note: To identify the signiﬁcantly enriched CNVs, we ﬁrst calculated the percentage of the number of cell lines with the speciﬁc CNV in the studied population and public database,
respectively, then performed two-percentage T-test. If the p value was b0.01, the CNV in the studied population was considered as signiﬁcantly enriched. The table was sorted based
on the sum of the number of ampliﬁcations and deletions.
Table 3
Novel CNVs detected in the 50 radiosensitive cell lines.
Chrom Start Stop Cytoband Total
Amp
Samples with Amp Total
Del
Samples
with Del
Length
(bps)
Overlapping Features
12 55851671 55933168 12q13.3 9 RS52, RS65, RS12, RS17, A RS-54, A RS-68,
B-70, B-72, RS63
0 81,498 MIR1228, NDUFA4L2, NXPH4, SHMT2,
STAC3, 51.20% of LRP1
17 35734619 35787071 17q21.2 6 RS52, RS17, A RS-68, B-36, B-79, RS63 0 52,453 GJD3, RARA
19 4978508 5043735 19p13.3 5 RS52, RS17, RS18, A RS-68, B-73 1 C RS-67 65,228 Contained within KDM4B
7 2845814 2947815 7p22.2 5 RS52, RS17, A RS-68, B-70, C RS-67 0 10,2002 34.82% of CARD11, 4.58% of GNA12
12 63222301 63275531 12q14.2 5 RS52, RS17, A RS-54, A RS-68, B-73 0 53,231 Region ends 15029 bp before RASSF3
19 5043735 5121724 19p13.3 5 RS52, RS17, RS18, A RS-68, B-73 0 77,990 Region overlaps with 78.05% of KDM4B
19 5121724 5285455 19p13.3 5 RS52, RS17, RS18, A RS-68, B-73 0 163,732 Region overlaps with 78.75% of PTPRS
19 52253908 52360202 19q13.32 5 RS52, RS17, A RS-68, B-70, C RS-77 0 106,295 ZC3H4, 32.22% of SAE1
22 47609092 47661828 22q13.32 4 RS52, RS17, A RS-68, B-70 1 52,737 Region starts 75341 bp after FAM19A5
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Fig. 1. The radiosensitivity of the 50 RS-LCLs measured by the colony survival assay (CSA). Normal range: >36%, intermediate radiosensitive range: 21–36%, radiosensitive range:
b21% [17].
99X. Li et al. / Genomics 99 (2012) 96–100In summary, the most signiﬁcant ﬁnding out of this study was the
dominance of chromosomal gains over losses. This ﬁnding enriched
the molecular mechanisms of RS. Our data suggest that the gene du-
plications through chromosomal gain may be an important, yet un-
derappreciated, pathway in regulating radiosensitive phenotype.
4. Methods and methods
4.1. Cell lines
The 50 RS-LCLs used in this study were derived from patients with
undiagnosed diseases [19]. Fig. 1 showed the radiosensitivity of these
50 RS-LCLs measured by the colony survival assay [20]. The diagnosticFig. 2. A common 81 kb gain on 12q13.3 was observed in nine RS-LCLs (See Table 3 for the
CNVs have been reported in this region.analyses established that they were free of any well established RS
syndromes such as A-T, NBS, MRE11 and DNA ligase [21]. Fifty such
RS-LCLs with unknown etiology were used in this study.
4.2. Affymetrix SNP6.0 array hybridization
Genomic DNA was extracted using standard procedures. SNP6.0
hybridization targets were prepared following manufacture's instruc-
tion. Brieﬂy, 500 ng of genomic DNAwas digested with the restriction
enzymes NspI and StyI (New England Biolabs, Ipswich, MA, USA).
After digestion, an adaptor was ligated to the restricted fragments,
which were then PCR-ampliﬁed. PCR products were puriﬁed, fragmen-
ted, end labeled, and then hybridized for 16–18 h to the Affymetrix 6.09 lines). This region overlapped with 5 RefSeq genes and miRNA1228. No polymorphic
Fig. 3. A comparison of miR1228 expression by QRT-PCR between 3 RS cell lines with
81 kb gain (RS12, RS52 and RS54) and 3 normal control (NAT8, CHOC6 and ESW-1).
Y axis represents normalized signal intensity. Data are expressed as mean±SD, pb0.01.
100 X. Li et al. / Genomics 99 (2012) 96–100chip at 49 °C in a GeneChip Hybridization Oven 640. The chips were
washed, stained in GeneChip Fluidic Station 450 and scanned with
Affymetrix 3000 7G scanner. Array quality was evaluated by using
Affymetrix GTC 4.0 software. Only arrays with contract QC>=0.4
and MAPDb=0.4 were accepted for further data analysis as per
manufacturer's instructions (Affymetrix, Santa Clara, CA). The analysis
was based on the assembly hg18/b36 of the human genome.
4.3. Data analysis
The CEL ﬁles were imported into Partek Genomics Suite 6.0
for copy number analysis. The Affy_SNP6_baseline_794Hapmap3_
122409.cnmodels (provided by Partek) was used as reference. We
used genomic segmentation method for detecting ampliﬁcations
and deletions. The segmentation parameters were set at the mini-
mum genomic markers=10 and pb=0.001. The region list parame-
ters were set at >=50 kb in size and >=10 markers within the 50 kb
in at least 5 samples (10% tested samples). The genes and polymor-
phic CNVs overlapped with these regions were reported using Find
Overlapping Genes tool. The CNVs on the x and y chromosomes
were not included in this analysis.
4.4. miRNA array hybridization and data analysis
Total RNA from cultured cells was extracted by the Qiagen miR-
Neasy mini kit. One microgram of total RNA was labeled using Exiqon
miRCURY LNA™ microRNA Power Labeling Kits. The labeled miRNA
was hybridized to Exiqon miRCURY LNA™ microRNA Array, v. 11.0.
The miRNA arrays were scanned using Axon GenePix 4000B scanner
(Axon Instruments, Foster City, CA) and the images were processed
using the GenePix Pro 6.1 software (Axon Instruments). The raw
data were normalized by using a set of invariant endogenous miRNAs
before comparison.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ygeno.2011.11.001.Acknowledgments
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